Cognition Therapeutics, Inc.
NASDAQ:CGTXBiotechnology
-$0.01 today
- Market cap
- $57.12M
- Beta
- 1.75
- P/E (TTM)
- -6.4
- EPS (TTM)
- -$0.22
Volume 0.33M
Average 1.23M
Balance Sheet
Inspect the capital base behind the business.
Assets
$48.39M
FY 2025 · Annual
+60.1% YoYLiabilities
$14.12M
FY 2025 · Annual
+22.9% YoYEquity
$34.27M
FY 2025 · Annual
+82.8% YoYBalance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 54.72M | 41.56M | 29.92M | 25.01M | 36.81M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 2.27M | 3.67M | 1.28M | 2.69M | 9.92M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 11K | 0 | 3.02M | 0 | 1.26M |
| Total Current Assets | 58.99M | 47.65M | 34.22M | 29.56M | 47.99M |
| Property, Plant & Equipment (Net) | 145K | 1.05M | 941K | 679K | 399K |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 0 | 1.73M | 0 | 0 | 0 |
| Total Non-current Assets | 145K | 2.78M | 941K | 679K | 399K |
| Total Assets | 59.14M | 50.43M | 35.16M | 30.23M | 48.39M |
| Account Payables | 4.17M | 3.22M | 3.7M | 1.98M | 1.12M |
| Short-term Debt | 0 | 634K | 544K | 279K | 307K |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 753K | 1.7M | 1.7M | 1.07M | 367K |
| Other Current Liabilities | 2.48M | 870K | 1.17M | 1.53M | 1.57M |
| Total Current Liabilities | 7.86M | 7.8M | 10.17M | 11.14M | 13.92M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | (695K) | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 1.69M | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 695K | 0 | 0 | 0 |
| Total Non-current Liabilities | 0 | 2.38M | 520K | 342K | 195K |
| Total Liabilities | 7.86M | 10.18M | 10.69M | 11.48M | 14.12M |
| Common Stock | 22K | 29K | 32K | 60K | 90K |
| Retained Earnings | (94M) | (115.4M) | (141.19M) | (175.16M) | (198.65M) |
| Accumulated OCI | (198K) | (199K) | (195K) | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 51.27M | 40.25M | 24.47M | 18.75M | 34.27M |
| Total Debt | 0 | 1.48M | 1.24M | 814K | 638K |
| Net Debt | (54.72M) | (40.08M) | (28.68M) | (24.2M) | (36.17M) |
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $31.1M |
| Receivables | $3.7M |
| Other Current | $1.0M |
| Total Current Assets | $35.8M |
| PP&E (Net) | $326.0K |
| Total Non-current Assets | $326.0K |
| Total Assets | $36.1M |
Analysis
Selected assets total $36.1M for Latest. The largest visible component is Cash & Equivalents at $31.1M, about 86.1% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Nov 5, 2026 | |
| 10-Q | Quarterly report | Nov 5, 2026 | |
| 8-K | Current report | Oct 22, 2026 | |
| 10-Q | Quarterly report | Aug 7, 2026 | |
| 8-K | Current report | Aug 6, 2026 |
How much cash does CGTX have?
Cognition Therapeutics, Inc. (CGTX) reported $36.81M in cash and equivalents in fiscal 2025.
How much debt does CGTX carry?
Cognition Therapeutics, Inc. (CGTX) reported $638,000.00 of total debt, with net debt of -$36.17M.
Continue the stock analysis
Jump to another research area for this company.